& Vinther, J
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer
It increases the expression of the oxidative/inflammatory gene NF-B as well as the expression of two NF-B inhibitors, TLE and ILBP
Research Applications Semaglutide is studied across several active laboratory research domains: GLP-1 receptor binding kinetics, agonist potency, and receptor desensitization studies cAMP signaling cascade and downstream PKA/EPAC pathway investigation Comparative incretin pharmacology isolating GLP-1R effects vs dual and triple agonists Pancreatic beta cell signaling and glucose-stimulated insulin response modeling Hypothalamic receptor expression and energy homeostasis research Fatty acid modification and albumin binding pharmacokinetic research GLP-1R expression profiling across tissue types in preclinical models Incretin effect studies comparing native GLP-1 vs structural analogs Why Research Laboratories Select GLP1-S Semaglutide is among the most studied GLP-1 receptor agonist analogs in current metabolic and endocrine research literature
A reversible fluorescent probe for real-time quantitative monitoring of cellular glutathione
